JBL XX: Oct. 2017

JBL Symposium XX – 2017


October 20-21, 2017; Harvard T. H. Chan School of Public Health

Snyder Auditorium (Kresge G1)

655 Huntington Ave., Boston

Theme: “The Interface Between Stress Responses and the Immune System in Health and Diseases”

Friday October 20th


John B. Little, M.D. James Stevens Simmons Professor of Radiobiology
Emeritus Department of Environmental Health
Harvard T.H. Chan School of Public Health

Opening Remarks
Michelle  A. Williams, Sc.D. Dean of the Faculty
Harvard T.H. Chan School of Public Health

1:15-4:30PM Session 1

1:15-2PM Kai Wucherpfennig, M.D., Ph.D. 
“Therapeutic reactivation of NKG2D-driven tumor immunity”
Chair Department of Cancer Immunology and Virology
Dana-Farber Cancer Institute

2-2:45PM Catherine J. Wu, M.D. 
“Building personal cancer vaccines”
Associate Professor of Medicine
Dana-Farber Cancer Institute and Harvard Medical School

2:45-3PM Break Outside G1

3-3:45PM Harvey Cantor, M.D. 
“The Treg Response and Tumor Immunity”
Baruj Benacerraf Professor of Microbiology & Immunobiology
Chairman, Department of Cancer Immunology & AIDS
Harvard Medical School

3:45-4:30PM Beth Stevens, Ph.D. 
“Immune Mechanisms of Synapse Loss in Health & Disease”
Associate Professor, Neurology
Harvard Medical School, Boston Children’s Hospital

4:30-6:30PM  Reception– Kresge Cafeteria


Saturday October 21st

8-9AM Breakfast -Kresge Cafeteria

9-12AM/PM Session 2

9-9:45AM John MacMicking, Ph.D. 
“Cell-autonomous immunity to infection: the art of self-defense”
Associate Professor of Microbial Pathogenesis and of Immunobiology
Yale Systems Biology Institute
Investigator, Howard Hughes Medical Institute

9:45-10:30AM  Xiaole Shirley Liu, Ph.D.
“Inference of gene signatures associated with response and resistance to targeted and immunotherapies”
Professor of Biostatistics
Harvard T.H. Chan School Of Public Health
Co-director, Center for Functional Cancer Epigenetics
Dana-Farber Cancer Institute

10:30-10:45AM Break Outside G1

10:45-11:30AM Ramnik Xavier, M.D., Ph.D. 
“Genetics, Microbes & Mucosal Immunity”
Chief, Gastrointestinal Unit & Director, Center for the Study of Inflammatory Bowel Disease
Massachusetts General Hospital
Kurt Isselbacher Professor of Medicine
Harvard Medical School

11:30-12:15 AM/PM Chih-Hao Lee, Ph.D. 
“Bioenergetic regulation in inflammatory macrophages by Bmal1-Hif-1a crosstalk”
Professor of Molecular Metabolism
Department of Molecular Metabolism
Harvard T.H. Chan School of Public Health

12:15-1:30PM Lunch– Kresge Cafeteria

1:30-4:45PM Session 3

1:30-2:15PM K. Dane Wittrup, Ph.D. 
“Synergistic Innate and Adaptive Immunotherapy of Cancer”
C.P. Dubbs Professor of Biological and Chemical Engineering
Koch Institute at Massachusetts Institute of Technology

2:15-3:00PM Lieping Chen, M.D., Ph.D. 
“Anti-PD Immunotherapy for human cancer”
United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, of Dermatology and of Medicine (Medical Oncology); Co-Director, Cancer Immunology Program
Yale Cancer Center

3-3:15PM Break -Outside G1

3:15-4:00PM Silvia Formenti, M.D. 
“DNA Damage Response and Immune Rejection of Cancer”
Chairman of the Department of Radiation Oncology
Weill Cornell
Associate Director
Meyer Cancer Center
Radiation Oncologist in Chief
NewYork-Presbyterian Hospital

4-4:45PM Wafik El-Deiry, M.D., Ph.D, FACP
“Imipridone ONC201, a first-in-class clinical stage cancer therapeutic triggers an integrated stress response and potent immune effects”
American Cancer Society Research Professor
Professor of Medical Oncology
Deputy Cancer Center Director for Translational Research
William Wikoff Smith Endowed Chair in Cancer Research
co-Leader, Molecular Therapeutics Program
Fox Chase Cancer Center